• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT LIBRARY
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES

Vy Spine Announces FDA Clearance for VyBrate VBR System

January 13, 2026 By SPINEMarketGroup

Bountiful, UT – January 13, 2025—Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VyBrate VBR System which is designed for use in both the cervical and thoracolumbar spine for vertebral body replacement surgery. 

The VyBrate VBR is an innovative device combining the osseointegration properties of the OXPEKK material and the novel OsteoVy lattice structure unique to Vy Spine. Additionally, the VyBrate VBR device is the first vertebral body replacement device on the market made using OsteoVy PEKK, developed in partnership with Oxford Performance Materials.

Unlike standard PEEK implants, PEKK implants have demonstrated bone ingrowth, no radiographic interference, no fibrotic tissue membrane formation, significant increase in bony apposition over time, and significantly higher push-out strength compared to PEEK.

Vy Spine’s proprietary OsteoVy lattice structure aids in bony integration as well as wicking –because PEKK is a hydrophilic material – to provide greater benefit as an interbody implant.

“This VyBrate VBR clearance is the latest in a long line of approvals for Vy Spine implants which utilize the unique qualities of our proprietary OsteoVy PEKK designs,” said Bret Berry, President of Product Development at Vy Spine. “As we continue to research OXPEKK and its unique characteristics, we have demonstrated that this unique composition accomplishes what we as an industry had always hoped PEEK would accomplish, but PEEK fell short. We are very excited about the OXPEKK material and our continued partnership with Oxford Performance Materials.”

About Vy Spine

Vy Spine was created through active internal development and the licensing of various proven technologies using innovative materials and designs. This comprehensive line of core spine products and newly developed specialty products allow us to meet the needs of both health care providers and surgeons. The company strives to outpace the competition by collaborating with key spine innovators while providing a flexible, cost-effective approach to spine care.

Learn more at www.vyspine.com.

About Oxford Performance Materials, Inc.

Oxford Performance Materials, Inc. was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM’s Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK brand, including coating technologies for a range of industrial and biomedical applications. The Company is a pioneer in 3D printing. OPM’s OsteoFab technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices, and OPM’s OXFAB production parts are designed for highly demanding industrial applications. 

“Vy Spine” “VyBrate” and “OsteoVy PEKK” are registered trademarks of Vy Spine.

“OXPEKK” “OXFAB” and “OsteoFab” are registered trademarks of Oxford Performance Materials.

Media Contact: Paul Williams, 310-569-0023, paul@medialinecommunications.com.

Paul Williams

President

MediaLine Communications

310/569-0023

paul@medialinecommunications.com

Filed Under: FDA APPROVED, NEWS Tagged With: 2026

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
CENTINEL SPINE
logo paradigm spine
TSUNAMI MEDICAL
VIKTOR HEGEDUS
RUDISHAUER
A-SPINE
GLOBAL biomedica
Z-MEDICAL
NORMMED
EMINENT SPINE
GENESYS SPINE
LfC
NGMEDICAL
RUTHLESS SPINE
syntropiq logo
bauispinelogo2025
ispine

GOLD SPONSORS

GSMEDICAL2025
SPINEGUARD2025

POPULAR POST LAST 90 DAYS

  • BROCHURES
  • Can a Spine Sales Rep Be as Crucial as the Implant Itself?
  • Johnson & Johnson Follows in Zimmer Biomet’s…
  • PRODUCT LIBRARY
  • Did Globus Medical’s Q3 Performance Reinforce Market…
  • 2025 Spine Product Launches and Trends: Where is the…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • (UPDATED 2025): Cervical Disc Prostheses – Global…
  • Beyond Sales: How Can Distributors Redefine Their…
  • 2025 Update: Posterior Cervical Spine Systems Market…
  • COMPANIES
  • First CD Horizon™ ModuLeX™ Deformity Surgery in…
  • Globus Medical Reports Preliminary Record Fourth…
  • Why Lumbar Artificial Disc Replacements Are Poised…
  • Top Six Spine Industry Milestones in 2025
  • FFX® Becomes the First Facet Cage Cleared by the FDA…
  • The End of an Era: The Former LDR Medical Site in…
  • Scientists Develop AxioMed Spinal Disc Replacement…
  • ATEC Announces Select Preliminary Financial Results…
  • LAST 5 VIDEOS PUBLISHED

    1. Taiwan OrthopedicBiotechnology:  Caduceus 
    2. Augmedics: Meet X2
    3. LEM Surgical: Dynamis NVIDIA Isaac Sim
    4. Globus Medical: ExcelsiusXR™
    5. Highridge Medical: FlareHawk Interbody 

     

     

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal

    Copyright © 2026 · SPINEMarketGroup